- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Total 4016 results
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma (DLBCL)United States, Japan, Australia, Italy, Canada, Germany, Norway, Netherlands, France, Austria
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma (DLBCL)United States
-
Jiangsu Cancer Institute & HospitalUnknownDiffuse Large B-Cell Lymphoma (DLBCL)China
-
Hospital Universitario Principe de AsturiasUnknownDiffuse Large B-Cell Lymphoma (DLBCL)Spain
-
Hospices Civils de LyonNot yet recruitingDiffuse Large B-cell Lymphoma (DLBCL) | CAR-T Cells TreatmentFrance
-
Acerta Pharma BVActive, not recruitingActivated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)United States, United Kingdom
-
Fujian Medical UniversityRecruitingRelapsed or Refractory DLBCL Patients With Either CD19 or CD20 PositiveChina
-
University of NebraskaBristol-Myers SquibbRecruitingFollicular Lymphoma | Refractory Non-Hodgkin Lymphoma | High-grade B-cell Lymphoma | DLBCL - Diffuse Large B Cell Lymphoma | Relapsed Non-Hodgkin Lymphoma | Mediastinal Large B-cell Lymphoma | Indolent B-Cell Non-Hodgkin LymphomaUnited States
-
Incyte Biosciences Italy S.r.lAdvice Pharma Group srlRecruiting
-
The First Affiliated Hospital of Xiamen UniversityShanxi Province Cancer Hospital; Sun Yat-sen University; Jiangsu Provincial People... and other collaboratorsRecruiting
-
Regeneron PharmaceuticalsRecruitingDiffuse Large B-cell Lymphoma (DLBCL)United States, Spain, Korea, Republic of, Belgium, Austria, Thailand, Singapore, Italy, Turkey, France, Australia, Czechia, Poland, Chile, United Kingdom, Germany
-
Ruijin HospitalNot yet recruitingLymphoma | DLBCL - Diffuse Large B Cell LymphomaChina
-
University Health Network, TorontoRecruitingDLBCL - Diffuse Large B Cell LymphomaCanada
-
Chengdu Zenitar Biomedical Technology Co., LtdRecruitingStudy of Purinostat Mesylate for Injection in the Treatment of Diffuse Large B-cell Lymphoma (DLBCL)Diffuse Large B Cell Lymphoma,DLBCLChina
-
Nordic Lymphoma GroupRoche Pharma AGRecruitingDiffuse Large B Cell Lymphoma | DLBCLFinland, Norway, Denmark, Italy, Sweden, Australia, New Zealand
-
University of Wisconsin, MadisonMedical College of WisconsinRecruitingCancer | Diffuse Large B Cell Lymphoma | DLBCLUnited States
-
Xynomic Pharmaceuticals, Inc.RecruitingDiffuse Large B-cell Lymphoma (DLBCL)China
-
Fudan UniversityXiangya Hospital of Central South University; Shanghai Changzheng Hospital; Baotou...Active, not recruitingDiffuse Large B-cell Lymphoma(DLBCL)China
-
Neumedicines Inc.UnknownLymphoma, Large B-Cell, Diffuse (DLBCL)
-
The Lymphoma Academic Research OrganisationLymphoma Study AssociationNot yet recruitingRefractory High Grade B-Cell Lymphoma | Diffuse Large B-cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell LymphomaFrance
-
Roswell Park Cancer InstituteRecruitingRecurrent Mantle Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Mantle Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma | Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell... and other conditionsUnited States
-
Huazhong University of Science and TechnologyShanghai IASO Biotechnology Co., LtdNot yet recruitingChronic Lymphocytic Leukemia (CLL) | Peripheral T-cell Lymphomas (PTCL) | CD5+ Relapsed/Refractory Hematopoietic Malignancies | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL)
-
Bristol-Myers SquibbCompletedLymphoma. Non-HodgkinGermany, Italy, United States, Spain, Netherlands, Australia, United Kingdom, Belgium, France, Canada, Sweden, Singapore
-
The Lymphoma Academic Research OrganisationActive, not recruitingRefractory Indolent Adult Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Diffuse Large B-Cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell Cell LymphomaFrance
-
Centre Hospitalier Universitaire, AmiensInstitut Bergonié; Centre Henri Becquerel; Saint-Louis Hospital, Paris, France; Henri Mondor University Hospital and other collaboratorsRecruitingChemotherapy | Elderly | Diffuse Large B-Cell Lymphoma (DLBCL), NosFrance
-
Stanford UniversityTerminatedLymphoma, Non-Hodgkin | Diffuse Large B-cell Lymphoma (DLBCL) | Lymphoma, B-cell | Malignant Lymphoma, Non-HodgkinUnited States
-
National Cancer Institute (NCI)CompletedBurkitt Lymphoma | High-grade B-cell Lymphoma | Diffuse Large B-Cell Lymphoma (DLBCL) | T-cell/Histocyte-rich Large B-cell Lymphoma | Germinal Center B-cell Type (GCB)United States
-
MingSight Pharmaceuticals, IncShenzhen MingSight Relin Pharmaceutical Co., LtdRecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Relapsed or Refractory B-cell Lymphoma | Marginal Zone Lymphoma (MZL)China
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); AmgenActive, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | CD20 Positive | Stage I Diffuse Large B-Cell Lymphoma | Stage II Diffuse Large B-Cell Lymphoma | Stage III Diffuse Large B-Cell Lymphoma | Stage IV Diffuse Large B-Cell LymphomaUnited States
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed B-Cell Non-Hodgkin Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma | Refractory Primary Mediastinal (Thymic)... and other conditionsUnited States
-
Kite, A Gilead CompanyApproved for marketingRelapsed/Refractory Diffuse Large B Cell Lymphoma | Relapsed/Refractory Primary Mediastinal B Cell Lymphoma | Relapsed/Refractory Transformed Follicular Lymphoma | Relapsed/Refractory High-Grade B-Cell LymphomaUnited States
-
BeiGeneRecruitingRelapsed Diffuse Large B-cell Lymphoma | Refractory Diffuse Large B-cell LymphomaChina
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)Merck Sharp & Dohme LLCRecruitingRelapsed Diffuse Large B-cell Lymphoma | Refractory Diffuse Large B-cell LymphomaAustralia, Spain, United States, France, Hungary, New Zealand, Poland, Serbia, Canada, Romania
-
GWT-TUD GmbHHoffmann-La RocheRecruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-cell LymphomaGermany, Spain, United Kingdom, Austria
-
ADC Therapeutics S.A.RecruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaJapan, Belgium, France, Italy, Spain, United Kingdom, United States, Israel, Hungary, Brazil, Switzerland, Poland, Canada, Puerto Rico, Czechia, Netherlands, China, Mexico, Argentina, Chile, Turkey
-
Hackensack Meridian HealthJanssen Scientific Affairs, LLC; Genentech, Inc.Active, not recruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLC; Celgene CorporationCompletedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States, United Kingdom, Belgium, Germany
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal Large B-Cell Lymphoma | Refractory Primary Mediastinal Large B-Cell LymphomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Jonsson Comprehensive Cancer CenterRecruitingProgressive Disease | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma | Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma | Refractory Transformed Follicular... and other conditionsUnited States
-
GenmabRecruitingAcute Myeloid Leukemia (AML) | Diffuse Large B Cell Lymphoma (DLBCL) | Relapsed or Refractory Multiple Myeloma (RRMM)United States, Korea, Republic of, Netherlands, Denmark, Australia, New Zealand, Poland, Spain, Sweden, Czechia, Malaysia, Greece, Moldova, Republic of, Georgia, Ukraine, France, Hungary, North Macedonia, Bosnia and Herzegovina and more
-
Novartis PharmaceuticalsWithdrawnDiffuse Large B-Cell Lymphoma (DLBCL)
-
Calibr, a division of Scripps ResearchActive, not recruitingTransformed Follicular Lymphoma | Burkitt Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Lymphoplasmacytic Lymphoma | Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Primary Mediastinal Large B Cell Lymphoma | Follicular Lymphoma (FL) | Marginal Zone Lymphoma... and other conditionsUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingDLBCL - Diffuse Large B Cell LymphomaItaly
-
Millennium Pharmaceuticals, Inc.CompletedNon-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)United States
-
Molecular Templates, Inc.TerminatedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell Lymphoma | Non-hodgkin Lymphoma,B CellUnited States
-
Beijing Yongtai Ruike Biotechnology Company LtdRecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-cell LymphomaChina
-
RenJi HospitalRecruitingDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma RefractoryChina